- Restoration of Brain Acid Soluble Protein 1 Inhibits Proliferation and Migration of Thyroid Cancer Cells
Run-Sheng Guo et al, 2016, Chinese Medical Journal CrossRef - Prognostic significance of Wilms' tumor 1 expression in patients with pancreatic ductal adenocarcinoma
Tomoya Kanai et al, 2018, Oncology Letters CrossRef - Emerging drugs for the treatment of triple-negative breast cancer: a focus on phase II immunotherapy trials
Peter E. Hall et al, 2021, Expert Opinion on Emerging Drugs CrossRef - Wilms’ tumor 1 (WT1) promotes ovarian cancer progression by regulating E-cadherin and ERK1/2 signaling
Yun Han et al, 2020, Cell Cycle CrossRef - microRNA-361 targets Wilms' tumor 1 to inhibit the growth, migration and invasion of non-small-cell lung cancer cells
Shuxiang Yang et al, 2016, Molecular Medicine Reports CrossRef - Wilms' tumor 1 (WT1) expression and prognosis in solid cancer patients: a systematic review and meta-analysis
Xiao-wei Qi et al, 2015, Scientific Reports CrossRef - Quantitative proteomics identifies brain acid soluble protein 1 (BASP1) as a prognostic biomarker candidate in pancreatic cancer tissue
Qimin Zhou et al, 2019, EBioMedicine CrossRef - Safety and immunogenicity of neoadjuvant treatment using WT1-immunotherapeutic in combination with standard therapy in patients with WT1-positive Stage II/III breast cancer: a randomized Phase I study
M. Higgins et al, 2017, Breast Cancer Research and Treatment CrossRef - MicroRNA-193a inhibits breast cancer proliferation and metastasis by downregulating WT1
FeiYan Xie et al, 2017, PLOS ONE CrossRef - Phase I/II clinical trial of a Wilms’ tumor 1-targeted dendritic cell vaccination-based immunotherapy in patients with advanced cancer
Wen Zhang et al, 2019, Cancer Immunology, Immunotherapy CrossRef - Regulation of breast cancer metastasis signaling by miRNAs
Belinda J. Petri et al, 2020, Cancer and Metastasis Reviews CrossRef - Correlation of Wilms’ Tumor 1 (WT1) with Oxidative Stress Markers and Expression of miR-361-5p; New Aspect of WT1 in Breast Cancer
Fariba Pishbin et al, 2023, Indian Journal of Clinical Biochemistry CrossRef - WT1 expression in vessels varies with histopathological grade in tumour-bearing and control tissue from patients with breast cancer
Richard J. McGregor et al, 2018, British Journal of Cancer CrossRef - Identification of differentially expressed lncRNAs and mRNAs in luminal-B breast cancer by RNA-sequencing
Cheng-Liang Yuan et al, 2019, BMC Cancer CrossRef - Identification of a Novel Epithelial–Mesenchymal Transition Gene Signature Predicting Survival in Patients With HNSCC
Wei Xin et al, 2021, Pathology and Oncology Research CrossRef - Correlation of miR-600 with WT1 Expression and its Potential Clinical Significance in Breast Cancer
Fariba Pishbin et al, 2021, Personalized Medicine CrossRef - Synergistic effects of combined treatment with histone deacetylase inhibitor suberoylanilide hydroxamic acid and TRAIL on human breast cancer cells
Weiqiang Zhou et al, 2016, Scientific Reports CrossRef - BRAF-activated WT1 contributes to cancer growth and regulates autophagy and apoptosis in papillary thyroid carcinoma
Xing Chen et al, 2022, Journal of Translational Medicine CrossRef - Overexpression of WT1 in all molecular subtypes of breast cancer and its impact on survival: exploring oncogenic and tumor suppressor roles of distinct WT1 isoforms
Hind Ben Haj Othmen et al, 2024, Molecular Biology Reports CrossRef - WT1 expression increases with malignancy and indicates unfavourable outcome in astrocytoma
Julian Rauscher et al, 2014, Journal of Clinical Pathology CrossRef - Differential expression of immunohistochemical markers in primary lung and breast cancers enriched for triple‐negative tumours
Elena Provenzano et al, 2016, Histopathology CrossRef - The role of WT1 isoforms in vasculogenic mimicry and metastatic potential of human triple negative breast cancer cells
Rassanee Bissanum et al, 2017, Biochemical and Biophysical Research Communications CrossRef